Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1991 Aug;64(2):333–338. doi: 10.1038/bjc.1991.301

Neuroendocrine differentiation and clinical behaviour in non-small cell lung tumours.

V Sundaresan 1, J G Reeve 1, S Stenning 1, S Stewart 1, N M Bleehen 1
PMCID: PMC1977503  PMID: 1654075

Abstract

The present study examines the relationship between neuroendocrine (NE) differentiation and the clinical behaviour of non-small cell lung cancer (NSCLC). Retrospective (n = 315) and prospective (n = 44) cohorts of non-small cell tumours were obtained from surgically treated cases of lung cancer, comprising 218 squamous cell carcinomas, 65 adenocarcinomas, 51 adenosquamous carcinomas, and 25 large cell undifferentiated carcinomas. Paraffin wax embedded and fresh frozen tissue sections were stained for the NE markers neurone specific enolase, creatine kinase-BB, bombesin, neurotensin, chromogranin A, synaptophysin and UJ-13A. The expression of two or more markers was observed in 30% of cases, and was taken to identify NE-NSCLC. A statistically significant correlation between nodal status and NE differentiation (P = 0.05), and disease stage and NE differentiation (P = 0.04) was observed. However, there was no correlation between NE differentiation and survival. These findings suggest that NE-NSCLC, analogous to SCLC is more highly metastatic than non-NE-NSCLC.

Full text

PDF
333

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Addis B. J., Hamid Q., Ibrahim N. B., Fahey M., Bloom S. R., Polak J. M. Immunohistochemical markers of small cell carcinoma and related neuroendocrine tumours of the lung. J Pathol. 1987 Oct;153(2):137–150. doi: 10.1002/path.1711530207. [DOI] [PubMed] [Google Scholar]
  2. Allan P. M., Garson J. A., Harper E. I., Asser U., Coakham H. B., Brownell B., Kemshead J. T. Biological characterization and clinical applications of a monoclonal antibody recognizing an antigen restricted to neuroectodermal tissues. Int J Cancer. 1983 May 15;31(5):591–598. doi: 10.1002/ijc.2910310510. [DOI] [PubMed] [Google Scholar]
  3. Baylin S. B., Abeloff M. D., Goodwin G., Carney D. N., Gazdar A. F. Activities of L-dopa decarboxylase and diamine oxidase (histaminase) in human lung cancers and decarboxylase as a marker for small (oat) cell cancer in cell culture. Cancer Res. 1980 Jun;40(6):1990–1994. [PubMed] [Google Scholar]
  4. Berendsen H. H., de Leij L., Poppema S., Postmus P. E., Boes A., Sluiter H. J., The H. Clinical characterization of non-small-cell lung cancer tumors showing neuroendocrine differentiation features. J Clin Oncol. 1989 Nov;7(11):1614–1620. doi: 10.1200/JCO.1989.7.11.1614. [DOI] [PubMed] [Google Scholar]
  5. Berger C. L., Goodwin G., Mendelsohn G., Eggleston J. C., Abeloff M. D., Aisner S., Baylin S. B. Endocrine-related biochemistry in the spectrum of human lung carcinoma. J Clin Endocrinol Metab. 1981 Aug;53(2):422–429. doi: 10.1210/jcem-53-2-422. [DOI] [PubMed] [Google Scholar]
  6. Bergh J., Esscher T., Steinholtz L., Nilsson K., Påhlman S. Immunocytochemical demonstration of neuron-specific enolase (NSE) in human lung cancers. Am J Clin Pathol. 1985 Jul;84(1):1–7. doi: 10.1093/ajcp/84.1.1. [DOI] [PubMed] [Google Scholar]
  7. Bishop A. E., Power R. F., Polak J. M. Markers for neuroendocrine differentiation. Pathol Res Pract. 1988 Apr;183(2):119–128. doi: 10.1016/s0344-0338(88)80040-2. [DOI] [PubMed] [Google Scholar]
  8. Dhillon A. P., Rode J., Dhillon D. P., Moss E., Thompson R. J., Spiro S. G., Corrin B. Neural markers in carcinoma of the lung. Br J Cancer. 1985 May;51(5):645–652. doi: 10.1038/bjc.1985.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dämmrich J., Ormanns W., Kahaly G., Schrezenmeir J. Multiple peptide hormone producing adenocarcinoma of lung with neurotensin and CRF-like immunoreactivity. Pathol Res Pract. 1988 Nov;183(6):670–674. doi: 10.1016/S0344-0338(88)80051-7. [DOI] [PubMed] [Google Scholar]
  10. Gatter K. C., Dunnill M. S., Pulford K. A., Heryet A., Mason D. Y. Human lung tumours: a correlation of antigenic profile with histological type. Histopathology. 1985 Aug;9(8):805–823. doi: 10.1111/j.1365-2559.1985.tb02868.x. [DOI] [PubMed] [Google Scholar]
  11. Gazdar A. F. Advances in the biology of non-small cell lung cancer. Chest. 1986 Apr;89(4 Suppl):277S–283S. doi: 10.1378/chest.89.4.277s. [DOI] [PubMed] [Google Scholar]
  12. Gazdar A. F., Helman L. J., Israel M. A., Russell E. K., Linnoila R. I., Mulshine J. L., Schuller H. M., Park J. G. Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin. Cancer Res. 1988 Jul 15;48(14):4078–4082. [PubMed] [Google Scholar]
  13. Gazdar A. F., Zweig M. H., Carney D. N., Van Steirteghen A. C., Baylin S. B., Minna J. D. Levels of creatine kinase and its BB isoenzyme in lung cancer specimens and cultures. Cancer Res. 1981 Jul;41(7):2773–2777. [PubMed] [Google Scholar]
  14. Gould V. E., Lee I., Wiedenmann B., Moll R., Chejfec G., Franke W. W. Synaptophysin: a novel marker for neurons, certain neuroendocrine cells, and their neoplasms. Hum Pathol. 1986 Oct;17(10):979–983. doi: 10.1016/s0046-8177(86)80080-6. [DOI] [PubMed] [Google Scholar]
  15. Graziano S. L., Mazid R., Newman N., Tatum A., Oler A., Mortimer J. A., Gullo J. J., DiFino S. M., Scalzo A. J. The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer. J Clin Oncol. 1989 Oct;7(10):1398–1406. doi: 10.1200/JCO.1989.7.10.1398. [DOI] [PubMed] [Google Scholar]
  16. Hamid Q. A., Addis B. J., Springall D. R., Ibrahim N. B., Ghatei M. A., Bloom S. R., Polak J. M. Expression of the C-terminal peptide of human pro-bombesin in 361 lung endocrine tumours, a reliable marker and possible prognostic indicator for small cell carcinoma. Virchows Arch A Pathol Anat Histopathol. 1987;411(2):185–192. doi: 10.1007/BF00712743. [DOI] [PubMed] [Google Scholar]
  17. Linnoila R. I., Mulshine J. L., Steinberg S. M., Funa K., Matthews M. J., Cotelingam J. D., Gazdar A. F. Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas. Am J Clin Pathol. 1988 Dec;90(6):641–652. doi: 10.1093/ajcp/90.6.641. [DOI] [PubMed] [Google Scholar]
  18. Moody T. W., Pert C. B., Gazdar A. F., Carney D. N., Minna J. D. High levels of intracellular bombesin characterize human small-cell lung carcinoma. Science. 1981 Dec 11;214(4526):1246–1248. doi: 10.1126/science.6272398. [DOI] [PubMed] [Google Scholar]
  19. Moss F., Bobrow L. G., Sheppard M. N., Griffiths M., Rowe D., Beverley P. C., Addis B., Souhami R. L. Expression of epithelial and neural antigens in small cell and non small cell lung carcinoma. J Pathol. 1986 Jun;149(2):103–111. doi: 10.1002/path.1711490205. [DOI] [PubMed] [Google Scholar]
  20. Patel K., Rossell R. J., Bourne S., Moore S. E., Walsh F. S., Kemshead J. T. Monoclonal antibody UJ13A recognizes the neural cell adhesion molecule (NCAM). Int J Cancer. 1989 Dec 15;44(6):1062–1068. doi: 10.1002/ijc.2910440621. [DOI] [PubMed] [Google Scholar]
  21. Rode J., Dhillon A. P., Doran J. F., Jackson P., Thompson R. J. PGP 9.5, a new marker for human neuroendocrine tumours. Histopathology. 1985 Feb;9(2):147–158. doi: 10.1111/j.1365-2559.1985.tb02431.x. [DOI] [PubMed] [Google Scholar]
  22. Rubery E. D., Doran J. F., Thompson R. J. Brain-type creatine kinase BB as a potential tumour marker--serum levels measured by radioimmunoassay in 1015 patients with histologically confirmed malignancies. Eur J Cancer Clin Oncol. 1982 Oct;18(10):951–956. doi: 10.1016/0277-5379(82)90243-7. [DOI] [PubMed] [Google Scholar]
  23. Said J. W., Vimadalal S., Nash G., Shintaku I. P., Heusser R. C., Sassoon A. F., Lloyd R. V. Immunoreactive neuron-specific enolase, bombesin, and chromogranin as markers for neuroendocrine lung tumors. Hum Pathol. 1985 Mar;16(3):236–240. doi: 10.1016/s0046-8177(85)80008-3. [DOI] [PubMed] [Google Scholar]
  24. Schmechel D., Marangos P. J., Brightman M. Neurone-specific enolase is a molecular marker for peripheral and central neuroendocrine cells. Nature. 1978 Dec 21;276(5690):834–836. doi: 10.1038/276834a0. [DOI] [PubMed] [Google Scholar]
  25. Tibshirani R. A plain man's guide to the proportional hazards model. Clin Invest Med. 1982;5(1):63–68. [PubMed] [Google Scholar]
  26. Wilkinson K. D., Lee K. M., Deshpande S., Duerksen-Hughes P., Boss J. M., Pohl J. The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science. 1989 Nov 3;246(4930):670–673. doi: 10.1126/science.2530630. [DOI] [PubMed] [Google Scholar]
  27. Yamaguchi K., Abe K., Adachi I., Kimura S., Suzuki M., Shimada A., Kodama T., Kameya T., Shimosato Y. Peptide hormone production in primary lung tumors. Recent Results Cancer Res. 1985;99:107–116. doi: 10.1007/978-3-642-82533-0_12. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES